CoChat

Priming of Alveolar Macrophages for Interleukin-8 Production in Patients With Idiopathic Pulmonary Fibrosis

Nakamura, H, Fujishima, S, Waki, Y, Urano, T, Sayama, K, Sakamaki, F, Terashima, T, Soejima, K, Tasaka, S, Ishizaka, A · 1995 · American journal of respiratory and critical care medicine

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

We evaluated the contribution of interleukin-8 (IL-8) to the pathogenesis of idiopathic pulmonary fibrosis (IPF) by studying bronchoalveolar lavage fluid (BALF) in eight patients with IPF in the chronically progressive phase, five patients with IPF in the subacutely progressive phase, eight patients with sarcoidosis (SAR), and eight control (CTL) subjects. IL-8 levels were not increased in the BALF of the patients with IPF in the chronic phase (11.3 +/- 8.8 pg/ml), nor in that of the SAR patients (13.8 +/- 7.8 pg/ml), whereas they were increased in the BALF of patients with IPF in the subacutely progressive phase (1.93 +/- 1.10 ng/ml). We then investigated extracellular and cell-associated IL-8 in lipopolysaccharide (LPS)-stimulated BALF cells to determine the IL-8-producing potential of alveolar macrophages (AM). Following LPS stimulation of BALF cells from patients with IPF in the chronic phase, both the extracellular IL-8 in culture fluid and the cell-associated IL-8 in AM were increased as compared with those for the CTL subjects (p < 0.05 and p < 0.05, respectively). These results suggest that AM of patients with IPF are primed for IL-8 production. We conclude that IL-8 may play a role in neutrophilic alveolitis, especially during the subacute phase of IPF.

Overview

Integrity signals

Registry

Crossref · 10.1164/ajrccm.152.5.7582298

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Cited by

See all 45

Metadata

Authors
Nakamura, H., Fujishima, S., Waki, Y., Urano, T., Sayama, K., Sakamaki, F., Terashima, T., Soejima, K., Tasaka, S., & Ishizaka, A.
Affiliations
Keio University (JP)
Venue
American journal of respiratory and critical care medicine
Published
1995-11-01
Volume
152
Issue
5
Pages
1579-1586
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W1994935924
Cited by
45
References
30
Citations by year
2024: 1 · 2023: 3 · 2019: 1 · 2017: 1 · 2014: 1 · 2013: 1
FWCI
3.95
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Genentech
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
idiopathic pulmonary fibrosis, interleukin-8, alveolar macrophages, bronchoalveolar lavage fluid, lipopolysaccharide stimulation, neutrophilic alveolitis, sarcoidosis, macrophage priming
MeSH terms
Acute Disease, Adult, Aged, Aged, 80 and over, Analysis of Variance, Bronchoalveolar Lavage Fluid, Chemotaxis, Leukocyte, Chronic Disease, Escherichia coli, Female, Humans, Lipopolysaccharides, Macrophage Activation, Male, Middle Aged, Neutrophils, Pulmonary Fibrosis, Stimulation, Chemical, Interleukin-8, Macrophages, Alveolar, Sarcoidosis, Pulmonary

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Priming of Alveolar Macrophages for Interleukin-8 Production in Patients With Idiopathic Pulmonary Fibrosis. https://app.cochat.ai/papers/10.1164/ajrccm.152.5.7582298
The paper
Nakamura, H., Fujishima, S., Waki, Y., Urano, T., Sayama, K., Sakamaki, F., Terashima, T., Soejima, K., Tasaka, S., & Ishizaka, A. (1995). Priming of Alveolar Macrophages for Interleukin-8 Production in Patients With Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. https://doi.org/10.1164/ajrccm.152.5.7582298

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.